The joint association of obesity and physical activity on cognitive function in Down syndrome
Year: 2025
Type: article
Abstract: Background Lifetime incidence of Alzheimer's disease (AD) in Down syndrome (DS) exceeds 90%. In adults with and without DS, low moderate-to-vigorous physical activity (MVPA) and obesity have independently been associated with AD. Research across other disease conditions indicates MVPA may attenuate some negative consequences of obesity. Objective To evaluate the potential joint association of obesity and MVPA on cognitive function in adults with DS. Methods Seventy-five adults with DS (age 39.1 years, 46.7% female) enrolled in the Alzheimer Biomarker Consortium-Down Syndrome (ABC-DS) study and completed a 7-day accelerometer protocol. Cognitive function was assessed using the ABC-DS cognitive battery. Participants were categorized with Obesity (body mass index (BMI) ≥ 30 kg/m 2 ) or No Obesity (BMI < 30 kg/m 2 ). A median split of MVPA was then used to create four groups: No Obesity/High PA (n = 18), No Obesity/Low PA (n = 16), Obesity/High PA (n = 20), and Obesity/Low PA (n = 21). Linear models were used to compare cognitive function across groups. Results The Obesity/High PA group performed better than the No Obesity/Low PA group for episodic memory (β = 4.86, p = 0.009), executive functioning (β = 3.07, p = 0.013), and dementia symptoms (β = −6.57, p = 0.022). The Obesity/High PA group also performed better than the Obesity/Low PA group for memory and orientation (β = 4.43, p = 0.012), social functioning (β = 4.52, p = 0.006), visuo-spatial processing (β = −2.39, p = 0.038), and overall dementia symptoms (β = −7.21, p = 0.016). There were no assessments for which either high PA group performed worse than either Low PA group. Conclusions Physical activity may benefit AD-related cognitive function in persons with DS, regardless of obesity status.
Source: Journal of Alzheimer s Disease
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1133076894, G115506582, G1257541548, G2202301513, G2824222223, Institute for Clinical and Translational Science, Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease, G630756267, G6371947672, University of Pittsburgh Clinical and Translational Science Institute, University of Kansas Alzheimer's Disease Research Center (KU ADRC), Body composition, physical activity, and cognitive function in Down syndrome, Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS), Multidisciplinary Research Training Program in Alzheimer's Disease and Related Disorders, NRSA Training Core
OpenAlex ID: W4415312412
